Legal Representation
Attorney
Sonali S. Srivastava
USPTO Deadlines
Next Deadline
85 days remaining
NOA E-Mailed - SOU Required
Due Date
April 29, 2026
Extension Available
Until October 29, 2026
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 11, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 10, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 10, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 10, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 29, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 28, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 28, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 28, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 25, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 25, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Apr 25, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Apr 25, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Apr 25, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 29, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 3, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 3, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 14, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 27, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 23, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 5, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 22, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neuropsychological diseases and disorders; pharmaceutical preparations for the prevention and treatment of medical conditions in the field of neuroscience
Classification
International Classes
005